Skip to content

Utility of Complete Repertory in the Homoeopathic Management of Rheumatoid Arthritis in 25-55 years age group

Utility of Complete Repertory in the Homoeopathic Management of Grade 1 and 2 Rheumatoid Arthritis cases in the age group 25-55 years assessed through the Simplified Disease Activity Index (SDAI) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080078
Enrollment
40
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: HOMOEOPATHIC MEDICINE: POTENCY VARIOUS DOSES AS PER NEED OF CASE FREQUENCY AS PER NEED OF CASE ROUTE OF ADMINISTRATION ORAL DURATION 10 MONTHS AS PER NEED OF CASE Control Intervention1:

Sponsors

DR SAMANAKHATUN JAVEDMEHDI SAIYED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals aged 25-55 years Patients diagnosed with Rheumatoid Arthritis as per American College of Rheumatology criteria Patients having GRADE 1 and Grade 2 Rheumatoid Arthritis Patients with a SDAI score less than twenty six point zero indicating low to moderate disease activity

Exclusion criteria

Exclusion criteria: Patients with other co-existing Autoimmune diseases such as SLE Psoriasis Sjogrens syndrome etc Pregnant and lactating women Patients with other systemic illness such as uncontrolled Diabetes advanced cardiovascular diseases severe renal or hepatic impairment

Design outcomes

Primary

MeasureTime frame
SDAI TOOL TO ASSESS REDUCTION IN DISEASE ACTIVITY OF RHEUMATOID ARTHRITISTimepoint: OUTCOME WILL ASSESSED AT BASELINE 5 MONTHS AND 10 MONTHS

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR SAMANAKHATUN JAVEDMEHDI SAIYED

SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE

shckalol@gmail.com9428000782

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026